Marshall Wace’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-66,483
Closed -$5.96M 4351
2021
Q4
$5.96M Buy
+66,483
New +$5.64M 0.01% 1237
2020
Q1
Sell
-16,249
Closed -$1.06M 2218
2019
Q4
$1.06M Buy
16,249
+5,258
+48% +$361K 0.01% 966
2019
Q3
$869K Buy
+10,991
New +$734K 0.01% 974
2017
Q1
Sell
-188,976
Closed -$8.45M 845
2016
Q4
$8.45M Sell
188,976
-897,024
-83% -$39.7M 0.06% 371
2016
Q3
$51.7M Buy
1,086,000
+1,016,589
+1,465% +$52.6M 0.37% 66
2016
Q2
$3.86M Sell
69,411
-217,652
-76% -$10.5M 0.03% 449
2016
Q1
$13.1M Buy
+287,063
New +$11M 0.13% 165
2014
Q3
Sell
-244,363
Closed -$6.08M 1097
2014
Q2
$6.08M Buy
244,363
+213,564
+693% +$4.68M 0.09% 242
2014
Q1
$642K Buy
+30,799
New +$670K 0.01% 545

Other funds holding CONE

Marshall Wace's CONE Position: Q1 2022 in Review

Marshall Wace sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 66,483 shares — an estimated $5.96M sold.

Marshall Wace first reported a position in CONE in Q1 2014 and held it in 9 quarters. The position peaked at $51.7M in Q3 2016. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Marshall Wace reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Marshall Wace sold 66,483 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $5.96M.
  • Marshall Wace first reported a position in CyrusOne Inc Common Stock in Q1 2014 and held it in 9 quarters.
  • Marshall Wace's CyrusOne Inc Common Stock position peaked at $51.7M in Q3 2016.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.